Patents by Inventor Luc Desnoyers

Luc Desnoyers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • KLOTHO BETA
    Publication number: 20220089780
    Abstract: The invention concerns uses of anti-KL? agents, and detection of KL? and/or FGF19 and/or FGFR4.
    Type: Application
    Filed: August 25, 2021
    Publication date: March 24, 2022
    Applicant: Genentech, Inc.
    Inventor: Luc Desnoyers
  • KLOTHO BETA
    Publication number: 20210284753
    Abstract: The invention concerns uses of anti-KL? agents, and detection of KL? and/or FGF19 and/or FGFR4.
    Type: Application
    Filed: November 10, 2020
    Publication date: September 16, 2021
    Applicant: Genentech, Inc.
    Inventor: Luc Desnoyers
  • KLOTHO BETA
    Publication number: 20180208677
    Abstract: The invention concerns uses of anti-KL? agents, and detection of KL? and/or FGF19 and/or FGFR4.
    Type: Application
    Filed: September 11, 2017
    Publication date: July 26, 2018
    Applicant: Genentech, Inc.
    Inventor: Luc Desnoyers
  • ANTI-FGFR4 ANTIBODIES AND METHODS OF USE
    Publication number: 20160237157
    Abstract: The invention provides anti-FGFR4 antibodies and methods of using the same.
    Type: Application
    Filed: January 13, 2016
    Publication date: August 18, 2016
    Inventors: Mark DENNIS, Luc DESNOYERS, Dorothy FRENCH
  • Anti-FGFR4 antibodies and methods of use
    Patent number: 9266955
    Abstract: The invention provides anti-FGFR4 antibodies and methods of using the same.
    Type: Grant
    Filed: October 4, 2013
    Date of Patent: February 23, 2016
    Assignee: Genentech, Inc.
    Inventors: Mark Dennis, Luc Desnoyers, Dorothy French
  • KLOTHO BETA
    Publication number: 20150368358
    Abstract: The invention concerns uses of anti-KL? agents, and detection of KL? and/or FGF19 and/or FGFR4.
    Type: Application
    Filed: March 26, 2015
    Publication date: December 24, 2015
    Applicant: GENENTECH, INC.
    Inventor: Luc Desnoyers
  • KLOTHO BETA
    Publication number: 20150132309
    Abstract: The invention concerns uses of anti-KL? agents, and detection of KL? and/or FGF19 and/or FGFR4.
    Type: Application
    Filed: December 22, 2014
    Publication date: May 14, 2015
    Applicant: GENENTECH, INC.
    Inventor: Luc Desnoyers
  • KLOTHO BETA
    Publication number: 20140363435
    Abstract: The invention concerns uses of anti-KL? agents, and detection of KL? and/or FGF19 and/or FGFR4.
    Type: Application
    Filed: June 12, 2014
    Publication date: December 11, 2014
    Applicant: GENENTECH, INC.
    Inventor: Luc Desnoyers
  • ANTI-FGFR4 ANTIBODIES AND METHODS OF USE
    Publication number: 20140037624
    Abstract: The invention provides anti-FGFR4 antibodies and methods of using the same.
    Type: Application
    Filed: October 4, 2013
    Publication date: February 6, 2014
    Applicant: GENENTECH, INC.
    Inventors: Mark Dennis, Luc Desnoyer, Dorothy French
  • Humanized anti-FGF19 antagonists and methods using same
    Patent number: 8409579
    Abstract: The present invention concerns antagonists of the FGF19/FGFR4 pathways, and the uses of same.
    Type: Grant
    Filed: June 29, 2012
    Date of Patent: April 2, 2013
    Assignee: Genentech, Inc.
    Inventors: Mark Dennis, Luc Desnoyers, Dorothy French
  • Anti-FGF19 antibodies and methods using same
    Patent number: 8293241
    Abstract: The invention provides anti-FGF19 antibodies, and compositions comprising and methods of using these antibodies, methods using anti-FGF19 antibodies, and methods comprising detection of FGF19 and/or FGFR4.
    Type: Grant
    Filed: December 8, 2011
    Date of Patent: October 23, 2012
    Assignee: Genentech, Inc.
    Inventors: Luc Desnoyers, Dorothy French
  • HUMANIZED ANTI-FGF19 ANTAGONISTS AND METHODS USING SAME
    Publication number: 20120263717
    Abstract: The present invention concerns antagonists of the FGF19/FGFR4 pathways, and the uses of same.
    Type: Application
    Filed: June 29, 2012
    Publication date: October 18, 2012
    Applicant: Genentech, Inc.
    Inventors: Mark Dennis, Luc Desnoyers, Dorothy French
  • Anti-FGF19 antibodies and methods using same
    Patent number: 8241633
    Abstract: The invention provides anti-FGF19 antibodies, and compositions comprising and methods of using these antibodies, methods using anti-FGF19 antibodies, and methods comprising detection of FGF19 and/or FGFR4.
    Type: Grant
    Filed: October 27, 2010
    Date of Patent: August 14, 2012
    Assignee: Genentech, Inc.
    Inventors: Luc Desnoyers, Dorothy French
  • Humanized anti-FGF19 antagonists and methods using same
    Patent number: 8236307
    Abstract: The present invention concerns antagonists of the FGF19/FGFR4 pathways, and the uses of same.
    Type: Grant
    Filed: August 1, 2008
    Date of Patent: August 7, 2012
    Assignee: Genentech, Inc.
    Inventors: Mark Dennis, Luc Desnoyers, Dorothy French
  • ANTI-FGF19 ANTIBODIES AND METHODS USING SAME
    Publication number: 20120128675
    Abstract: The invention provides anti-FGF19 antibodies, and compositions comprising and methods of using these antibodies, methods using anti-FGF19 antibodies, and methods comprising detection of FGF19 and/or FGFR4.
    Type: Application
    Filed: December 8, 2011
    Publication date: May 24, 2012
    Inventors: Luc DESNOYERS, Dorothy French
  • Methods of treatment using WISP polypeptides
    Patent number: 8138152
    Abstract: The present invention relates to methods for the treatment and repair of cartilage, including cartilage damaged by injury or degenerative cartilagenous disorders, including arthritis, comprising the administration of WISP polypeptide. Optionally, the administration may be in combination with one or more cartilage agents (e.g., peptide growth factor, catabolism antagonist, osteo-, synovial, anti-inflammatory factor). Alternatively, the method provides for the treatment and repair of cartilage damaged by injury or degenerative cartilagenous disorders comprising the administration of WISP polypeptide in combination with standard surgical techniques. Alternatively, the method provides for the treatment and repair of cartilage damaged by injury or degenerative cartilagenous disorders comprising the administration of chondrocytes previously treated with an effective amount of WISP polypeptide.
    Type: Grant
    Filed: August 7, 2009
    Date of Patent: March 20, 2012
    Assignee: Genentech, Inc.
    Inventors: Luc Desnoyers, Ellen H. Filvaroff, Diane Pennica
  • ANTI-FGF19 ANTIBODIES AND METHODS USING SAME
    Publication number: 20110086032
    Abstract: The invention provides anti-FGF19 antibodies, and compositions comprising and methods of using these antibodies, methods using anti-FGF19 antibodies, and methods comprising detection of FGF19 and/or FGFR4.
    Type: Application
    Filed: October 27, 2010
    Publication date: April 14, 2011
    Applicant: GENENTECH, INC.
    Inventors: LUC DESNOYERS, DOROTHY FRENCH
  • HUMANIZED ANTI-FGF19 ANTAGONISTS AND METHODS USING SAME
    Publication number: 20110076262
    Abstract: The present invention concerns antagonists of the FGF19/FGFR4 pathways, and the uses of same.
    Type: Application
    Filed: August 1, 2008
    Publication date: March 31, 2011
    Inventors: Mark Dennis, Luc Desnoyers, Dorothy French
  • Polynucleotide encoding an anti-FGF19 antibody
    Patent number: 7846691
    Abstract: The invention provides anti-FGF19 antibodies, and compositions comprising and methods of using these antibodies, methods using anti-FGF19 antibodies, and methods comprising detection of FGF19 and/or FGFR4.
    Type: Grant
    Filed: January 22, 2010
    Date of Patent: December 7, 2010
    Assignee: Genentech, Inc.
    Inventors: Luc Desnoyers, Dorothy French
  • Secreted and transmembrane polypeptides and nucleic acids encoding the same
    Publication number: 20100261217
    Abstract: The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
    Type: Application
    Filed: December 19, 2006
    Publication date: October 14, 2010
    Inventors: Kevin P. Baker, Luc Desnoyers, Mary E. Gerritsen, Audrey Goddard, Paul J. Godowski, J. Christopher Grimaldi, Austin L. Gurney, Victoria Smith, Jean-Philippe F. Stephan, Colin K. Watanabe, William I. Wood